GLENMEDE TRUST CO NA - IONIS PHARMACEUTICALS INC ownership

IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 388 filers reported holding IONIS PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 1.50 and the average weighting 0.2%.

Quarter-by-quarter ownership
GLENMEDE TRUST CO NA ownership history of IONIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2020$9,000
-18.2%
2000.0%0.00%
Q2 2020$11,000
-71.1%
200
-69.0%
0.00%
Q1 2020$38,0000.0%6460.0%0.00%
Q4 2019$38,000
+245.5%
646
+213.6%
0.00%
Q3 2019$11,000
-8.3%
2060.0%0.00%
Q2 2019$12,000
-25.0%
2060.0%0.00%
Q1 2019$16,000
+45.5%
206
-6.8%
0.00%
Q4 2018$11,000
+10.0%
221
+10.5%
0.00%
Q3 2018$10,0000.0%2000.0%0.00%
Q1 2018$10,0000.0%2000.0%0.00%
Q4 2017$10,0000.0%2000.0%0.00%
Q3 2017$10,000
-65.5%
200
-72.4%
0.00%
Q2 2017$29,0000.0%7240.0%0.00%
Q1 2017$29,000
-12.1%
724
+2.0%
0.00%
Q4 2016$33,000
+32.0%
7100.0%0.00%
Q3 2016$25,000
-34.2%
710
-58.5%
0.00%
Q2 2016$38,000
+850.0%
1,710
+1454.5%
0.00%
Q1 2016$4,000
-33.3%
1100.0%0.00%
Q4 2015$6,0001100.00%
Other shareholders
IONIS PHARMACEUTICALS INC shareholders Q4 2019
NameSharesValueWeighting ↓
Bellevue Group AG 9,930,245$396,117,0003.87%
Sicart Associates LLC 368,409$14,696,0003.50%
Camber Capital Management LP 2,000,000$79,780,0002.69%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 181,781$7,251,0001.91%
SECTOR GAMMA AS 263,488$10,511,0001.86%
Parkman Healthcare Partners LLC 136,380$5,440,0001.19%
Eversept Partners, LP 442,000$17,631,3801.18%
Affinity Asset Advisors, LLC 75,000$2,992,0001.07%
TANAKA CAPITAL MANAGEMENT INC 16,661$665,0000.90%
Sonora Investment Management, LLC 168,665$6,728,0000.88%
View complete list of IONIS PHARMACEUTICALS INC shareholders